TFF Pharmaceuticals to Participate at The H.C. Wainwright 24th Annual Global Investment Conference
September 06, 2022 08:00 ET
|
TFF Pharmaceuticals, Inc.
FORT WORTH, Texas, Sept. 06, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
TFF Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
August 11, 2022 16:05 ET
|
TFF Pharmaceuticals, Inc.
Phase 2 Inhaled Voriconazole Powder and Inhaled Tacrolimus Powder Programs Continue to Advance Expands R&D Operations with New Austin, TX Facility Recent Feasibility Work Confirms...
TFF Pharmaceuticals to Hold Second Quarter 2022 Financial and Business Results Conference Call on August 11, 2022
August 02, 2022 16:05 ET
|
TFF Pharmaceuticals, Inc.
FORT WORTH, Texas, Aug. 02, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
TFF Pharmaceuticals Expands R&D Operations with New Austin Facility
July 14, 2022 08:00 ET
|
TFF Pharmaceuticals, Inc.
New Facility in Austin Will Enable Increased Capacity for Internal Pipeline Assets While Accommodating Growing Interest in Partnered Projects Significantly Increases Manufacturing Capabilities to...
TFF Pharmaceuticals to Participate at The JMP Securities Life Sciences Conference
June 09, 2022 08:00 ET
|
TFF Pharmaceuticals, Inc.
FORT WORTH, Texas, June 09, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
TFF Pharmaceuticals to Participate at the Jefferies Healthcare Conference
June 01, 2022 08:00 ET
|
TFF Pharmaceuticals, Inc.
FORT WORTH, Texas, June 01, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference
May 20, 2022 09:32 ET
|
TFF Pharmaceuticals, Inc.
FORT WORTH, Texas, May 20, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
May 11, 2022 16:01 ET
|
TFF Pharmaceuticals, Inc.
Announced Collaboration with Catalent to Further Expand Thin Film Freezing Applications with a Focus on Biologic Drug Development Announced Second CRADA Agreement with USAMRIID and Geneva Foundation...
TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)
May 02, 2022 08:00 ET
|
TFF Pharmaceuticals, Inc.
Thin Film Freezing Technology Co-Inventor Dr. Robert O. Williams III to Deliver Platform Presentation of Data on Stabilizing and Delivering Antivirals, Antibodies and Vaccines using Thin Film Freezing...
TFF Pharmaceuticals to Hold First Quarter 2022 Financial and Business Results Conference Call on May 11, 2022
April 29, 2022 07:30 ET
|
TFF Pharmaceuticals, Inc.
FORT WORTH, Texas, April 29, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...